Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Clin Genet. 2018 Sep 24;94(6):502–511. doi: 10.1111/cge.13440

Table 3:

Studies that have evaluated pulmonary functions in Ol

Study Number enrolled Age Major Findings
Falvo et al 1973 “severe disease” 4
“moderate disease” 6
“mild disease” 1
4–34 yrs
  • Reduction of VC and increase in RV and RV/TLC ratio were found only in patients with kyphoscoliosis

Widmann et al 1999 “OI tarda” 8
“OI congenita” 7
21–45 yrs
  • “Restrictive disease” in 53%

  • Diminished VC with scoliosis of greater than 600

Takken et al 2004 OI I 17 8–21 yrs
  • Decrease in percent predicted FEV1 and FVC with normalized height but not measured height

  • Decreased exercise tolerance

Thiele et al 2012 OI III 23
OI IV 23
4–20 yrs
  • FVC, VC, and TLC decrease with age

  • Decline in volumes is greater in type III OI

  • Scoliosis contributes to decline in volumes; however decline observed even in absence of scoliosis

  • 57% diagnosed with “restrictive disease”

  • 22% diagnosed with “obstructive disease”

LoMauro et al 2012 OI III 7
OI IV 15
Mean (SD) OI III 26 (16) yrs
Mean (SD) OI IV 16 (11) yrs
  • Lower FVC and FEV1 compared to predicted values

  • Paradoxical movement of chest wall and thoracoabdominal asynchrony in type III OI

Wekre et al 2014 OI I 60
OI III 3
OI IV 10
Mean (SD)
44 (12)
  • Use of arm span-imputed height decreased percent predicted FVC and FEV1 compared to measure height

  • FVC and FEV1 correlated negatively with scoliosis